KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Proteus vulgaris (clinical isolate)

• Proteus vulgaris
• Proteus vulgaris (08601)
• Proteus vulgaris (1405 + β-lactamase positive)
• Proteus vulgaris (1699 + β-lactamase positive)
• Proteus vulgaris (1765 + β-lactamase positive)
• Proteus vulgaris (1781 + β-lactamase positive)
• Proteus vulgaris (A161)
• Proteus vulgaris (ampicillin-resistant + cefazolin-resistant)
• Proteus vulgaris (ATCC 13315)
• Proteus vulgaris (ATCC 4635)
• Proteus vulgaris (ATCC 6380)
• Proteus vulgaris (ATCC 6830)
• Proteus vulgaris (clinical isolate)
• Proteus vulgaris (CMCC(B) 49001)
• Proteus vulgaris (CNUR 6)
• Proteus vulgaris (CSIR 0030)
• Proteus vulgaris (ESBL)
• Proteus vulgaris (GN4413 + cephalosporin-resistant)
• Proteus vulgaris (GN76 + cephalosporin-resistant)
• Proteus vulgaris (GN7919 + cephalosporin-resistant)
• Proteus vulgaris (GN7919)
• Proteus vulgaris (HX-19)
• Proteus vulgaris (Hyperproducing amp(C))
• Proteus vulgaris (IFO 3851)
• Proteus vulgaris (IFO 3988)
• Proteus vulgaris (IID OX-19)
• Proteus vulgaris (indole-positive)
• Proteus vulgaris (Inducible amp(C))
• Proteus vulgaris (KUKEM 1329)
• Proteus vulgaris (KZN)
• Proteus vulgaris (NCIB 4157)
• Proteus vulgaris (NCIM 2027)
• Proteus vulgaris (NCIM 2857)
• Proteus vulgaris (NCTC 4635)
• Proteus vulgaris (non-ESBL)
• Proteus vulgaris (OX-19)
• Proteus vulgaris (OX-K)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8